InMode stock holds steady as investors eye latest growth figures
Published on 09/03/2026 at 15:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
InMode Ltd (ISIN IL0011356806) stock is trading around a market capitalization of about USD 864.9 million as of September 3, 2026, giving investors a mid-cap exposure to minimally invasive aesthetic and surgical technologies according to market data compiled by Yahoo Finance.
Latest fundamentals show solid profitability
According to analyst and fundamentals data for InMode on Yahoo Finance, the company’s most recently reported annual revenue was approximately USD 110.0 million for its latest fiscal year within the past 24 months, with net income of about USD 38.0 million for the same period, illustrating a net margin in the mid-30 percent range.
That revenue represents double-digit growth versus a prior historical year in which revenue was around USD 95.0 million, meaning sales expanded by roughly 15.8 percent in that comparison period based on the same data set.
Analyst expectations and valuation context
The same overview of InMode on Yahoo Finance shows that the current consensus expects earnings per share for the ongoing fiscal year to be in the range of USD 1.50, compared with an EPS of roughly USD 1.30 in the previous fiscal year, implying anticipated EPS growth of about 15.4 percent.
On this basis, if the stock price is around USD 15.03 as indicated in recent market data citations alongside InMode’s name, the shares are valued at about 10.0 times the expected EPS, placing the valuation in a moderate range compared with many growth-focused medical technology peers.
Background on InMode stock and key figures
Further background information, charts and news on InMode stock can be found in the company overview and market data pages.
Flagship minimally invasive platforms
InMode is best known in the market for its radiofrequency-assisted lipolysis and skin tightening platforms such as the BodyTite and FaceTite systems, which are used by aesthetic physicians to perform minimally invasive contouring procedures with less downtime than traditional surgery.
Historically, these platforms have helped drive device and consumable revenue growth, and the latest available figures indicate that the company continues to expand its installed base and recurring consumables revenue as aesthetic providers adopt energy-based solutions.
Stock level and investor perspective
With a recent share price indication around USD 15.03 for InMode stock and a market capitalization close to USD 864.9 million as of early September 2026, investors are watching how upcoming earnings and guidance will confirm whether the double-digit growth in revenue and EPS seen in the latest fiscal year can be maintained.
InMode stock facts
- Company: InMode Ltd.
- ISIN: IL0011356806
- Ticker: INMD
- Trading venue: NASDAQ
- Price (as of September 3, 2026): 15.03 USD
- Market capitalization: 864.9 million USD (as of September 3, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: None of the major headline indices
